Citius Oncology Inc (NASDAQ: CTOR) is -82.93% lower on its value in year-to-date trading and has touched a low of $0.55 and a high of $49.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CTOR stock was last observed hovering at around $1.82 in the last trading session, with the day’s gains setting it 0.13%.
Currently trading at $1.95, the stock is -37.61% and -3.22% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.12 million and changing 7.14% at the moment leaves the stock 52.98% off its SMA200. CTOR registered 69.57% gain for a year compared to 6-month gain of 47.73%. The firm has a 50-day simple moving average (SMA 50) of $2.01496 and a 200-day simple moving average (SMA200) of $1.274665.
The stock witnessed a -26.69% loss in the last 1 month and extending the period to 3 months gives it a 191.04%, and is 21.88% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 22.78% over the week and 26.50% over the month.
Fwd P/E is 39.00. Distance from 52-week low is 254.16% and -96.02% from its 52-week high. The company has generated returns on investments over the last 12 months (-52.88%).
The EPS is expected to shrink by -54.84% this year
8.0 institutions hold shares in Citius Oncology Inc (CTOR), with institutional investors hold 4.51% of the company’s shares. The shares outstanding are 71.55M, and float is at 3.86M with Short Float at 9.48%. Institutions hold 0.60% of the Float.
